ArticleClinical and experimental immunology2013

Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2.

A E Østvik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.